Financial Reporting Resource Center: Coronavirus considerations

Coronavirus: Financial reporting considerations

It's important for entities to consider how the coronavirus affects their financial reporting. Our white paper can provide some insight.

FASB finalizes limited effective-date deferrals for ASC 606 and 842

Coronavirus: PPP loans and revolvers with a fluctuating borrowing base

FASB expands ASC 606 deferral and approves limited deferral of ASC 842

GASB postpones effective dates of certain pronouncements

Single Audit requirements: SBA loan programs

Cash flow hedge accounting affected by the COVID-19 pandemic

Updates to Coronavirus: Financial reporting considerations

IASB discusses COVID-19-related matters

Updated white paper: Fundamentals of debt classification

Webinar on interagency statement on loan modifications and reporting

Proposed deferral for certain entities: ASC 606 and ASC 842

GASB proposes to postpone effective dates of certain pronouncements

Coronavirus: FASB staff provides guidance on various issues

FDIC FAQ for financial institutions affected by COVID-19

COVID-19: Auditor and audit committee considerations

FDIC announces changes to community bank leverage ratio

FASB to provide limited deferrals for ASC 606 and ASC 842

Revised interim final rule on CECL capital transition

Interim goodwill impairment testing by SEC filers

IFRS 9 and COVID-19

Coronavirus: Going concern, risks and uncertainties

Financial reporting implications: CARES Act and recent SEC relief

Temporary relief for financial institutions: TDR accounting

Temporary CECL relief for certain insured depository institutions

SEC extends conditional relief and issues disclosure guidance

Coronavirus: Interagency statement on loan modifications

Effects of the coronavirus on financial reporting

COVID-19: IFRS financial reporting implications

Coronavirus: Financial reporting considerations